ID   CDK6_HUMAN              Reviewed;         326 AA.
AC   Q00534;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   05-OCT-2010, entry version 120.
DE   RecName: Full=Cell division protein kinase 6;
DE            EC=2.7.11.22;
DE   AltName: Full=Serine/threonine-protein kinase PLSTIRE;
GN   Name=CDK6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=92347325; PubMed=1639063;
RA   Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C.,
RA   Harlow E., Tsai L.-H.;
RT   "A family of human cdc2-related protein kinases.";
RL   EMBO J. 11:2909-2917(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22737999; PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-13 AND TYR-24, AND MASS
RP   SPECTROMETRY.
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [6]
RP   INDUCTION, AND MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells
RT   reveal differential cellular gene expression in response to
RT   enterovirus 71 infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24; THR-49; SER-57;
RP   THR-70; SER-86; THR-154; SER-155; SER-223; SER-290; SER-317 AND
RP   THR-325, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-43 AND LYS-264, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF COMPLEXES WITH INK4A AND
RP   INK4D.
RX   MEDLINE=98421670; PubMed=9751050; DOI=10.1038/26155;
RA   Russo A.A., Tong L., Lee J.O., Jeffrey P.D., Pavletich N.P.;
RT   "Structural basis for inhibition of the cyclin-dependent kinase Cdk6
RT   by the tumour suppressor p16INK4a.";
RL   Nature 395:237-243(1998).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASN-110 AND LEU-199.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probably involved in the control of the cell cycle.
CC       Interacts with D-type G1 cyclins.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       P24385:CCND1; NbExp=1; IntAct=EBI-295663, EBI-375001;
CC       P30281:CCND3; NbExp=1; IntAct=EBI-295663, EBI-375013;
CC       Q16543:CDC37; NbExp=1; IntAct=EBI-295663, EBI-295634;
CC       P38936:CDKN1A; NbExp=1; IntAct=EBI-295663, EBI-375077;
CC       O77617:CDKN2A (xeno); NbExp=1; IntAct=EBI-295663, EBI-1542658;
CC       P42771:CDKN2A; NbExp=5; IntAct=EBI-295663, EBI-375053;
CC       P42773:CDKN2C; NbExp=2; IntAct=EBI-295663, EBI-711290;
CC       Q60773:Cdkn2d (xeno); NbExp=1; IntAct=EBI-295663, EBI-1027163;
CC       Q7L590:MCM10; NbExp=1; IntAct=EBI-295663, EBI-374912;
CC       P49736:MCM2; NbExp=1; IntAct=EBI-295663, EBI-374819;
CC   -!- INDUCTION: Down-regulated in response to enterovirus 71 (EV71)
CC       infection.
CC   -!- POLYMORPHISM: Genetic variations in CDK6 influences stature as a
CC       quantitative trait type 11 (STQTL11) [MIM:612223]. Adult height is
CC       an easily observable and highly heritable complex continuous
CC       trait. Because of this, it is a model trait for studying genetic
CC       influence on quantitative traits.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdk6/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X66365; CAA47008.1; -; mRNA.
DR   EMBL; AY128534; AAM76970.1; -; Genomic_DNA.
DR   EMBL; AC000065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004128; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004011; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC052264; AAH52264.1; -; mRNA.
DR   IPI; IPI00023529; -.
DR   PIR; S23387; S23387.
DR   RefSeq; NP_001138778.1; -.
DR   RefSeq; NP_001250.1; -.
DR   UniGene; Hs.119882; -.
DR   PDB; 1BI7; X-ray; 3.40 A; A=1-326.
DR   PDB; 1BI8; X-ray; 2.80 A; A/C=1-326.
DR   PDB; 1BLX; X-ray; 1.90 A; A=1-326.
DR   PDB; 1G3N; X-ray; 2.90 A; A/E=1-326.
DR   PDB; 1JOW; X-ray; 3.10 A; B=1-308.
DR   PDB; 1XO2; X-ray; 2.90 A; B=1-308.
DR   PDB; 2EUF; X-ray; 3.00 A; B=1-308.
DR   PDB; 2F2C; X-ray; 2.80 A; B=1-308.
DR   PDBsum; 1BI7; -.
DR   PDBsum; 1BI8; -.
DR   PDBsum; 1BLX; -.
DR   PDBsum; 1G3N; -.
DR   PDBsum; 1JOW; -.
DR   PDBsum; 1XO2; -.
DR   PDBsum; 2EUF; -.
DR   PDBsum; 2F2C; -.
DR   ProteinModelPortal; Q00534; -.
DR   DIP; DIP-687N; -.
DR   IntAct; Q00534; 26.
DR   MINT; MINT-232049; -.
DR   STRING; Q00534; -.
DR   PhosphoSite; Q00534; -.
DR   PeptideAtlas; Q00534; -.
DR   PRIDE; Q00534; -.
DR   Ensembl; ENST00000265734; ENSP00000265734; ENSG00000105810.
DR   Ensembl; ENST00000424848; ENSP00000397087; ENSG00000105810.
DR   GeneID; 1021; -.
DR   KEGG; hsa:1021; -.
DR   UCSC; uc003ume.1; human.
DR   CTD; 1021; -.
DR   GeneCards; GC07M092234; -.
DR   H-InvDB; HIX0006844; -.
DR   HGNC; HGNC:1777; CDK6.
DR   HPA; CAB004363; -.
DR   HPA; HPA002637; -.
DR   MIM; 603368; gene.
DR   MIM; 612223; phenotype.
DR   PharmGKB; PA103; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q00534; -.
DR   OMA; NTSEMNT; -.
DR   OrthoDB; EOG9DNHQB; -.
DR   PhylomeDB; Q00534; -.
DR   BRENDA; 2.7.11.22; 247.
DR   Pathway_Interaction_DB; ar_pathway; Coregulation of Androgen receptor activity.
DR   Pathway_Interaction_DB; il2_stat5pathway; IL2 signaling events mediated by STAT5.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   BindingDB; Q00534; -.
DR   NextBio; 4291; -.
DR   ArrayExpress; Q00534; -.
DR   Bgee; Q00534; -.
DR   CleanEx; HS_CDK6; -.
DR   Genevestigator; Q00534; -.
DR   GermOnline; ENSG00000105810; Homo sapiens.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme ...; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0001726; C:ruffle; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:BHF-UCL.
DR   GO; GO:0030332; F:cyclin binding; IPI:BHF-UCL.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0043697; P:cell dedifferentiation; IMP:BHF-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000080; P:G1 phase of mitotic cell cycle; IEP:BHF-UCL.
DR   GO; GO:0042063; P:gliogenesis; IMP:BHF-UCL.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.
DR   GO; GO:0050680; P:negative regulation of epithelial cell prol...; IMP:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast different...; IDA:BHF-UCL.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IDA:BHF-UCL.
DR   GO; GO:0048146; P:positive regulation of fibroblast prolifera...; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0045646; P:regulation of erythrocyte differentiation; IMP:BHF-UCL.
DR   GO; GO:0010468; P:regulation of gene expression; IDA:BHF-UCL.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    326       Cell division protein kinase 6.
FT                                /FTId=PRO_0000085789.
FT   DOMAIN       13    300       Protein kinase.
FT   NP_BIND      19     27       ATP (By similarity).
FT   ACT_SITE    145    145       Proton acceptor.
FT   BINDING      43     43       ATP (By similarity).
FT   MOD_RES      13     13       Phosphotyrosine.
FT   MOD_RES      24     24       Phosphotyrosine.
FT   MOD_RES      43     43       N6-acetyllysine.
FT   MOD_RES      49     49       Phosphothreonine.
FT   MOD_RES      57     57       Phosphoserine.
FT   MOD_RES      70     70       Phosphothreonine.
FT   MOD_RES      86     86       Phosphoserine.
FT   MOD_RES     154    154       Phosphothreonine.
FT   MOD_RES     155    155       Phosphoserine.
FT   MOD_RES     223    223       Phosphoserine.
FT   MOD_RES     264    264       N6-acetyllysine.
FT   MOD_RES     290    290       Phosphoserine.
FT   MOD_RES     317    317       Phosphoserine.
FT   MOD_RES     325    325       Phosphothreonine.
FT   VARIANT     110    110       D -> N (in dbSNP:rs35654944).
FT                                /FTId=VAR_041978.
FT   VARIANT     199    199       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041979.
FT   HELIX         9     11
FT   STRAND       13     22
FT   STRAND       25     32
FT   TURN         33     37
FT   STRAND       39     49
FT   HELIX        58     70
FT   STRAND       79     87
FT   STRAND       89     99
FT   HELIX       105    111
FT   HELIX       119    138
FT   HELIX       148    150
FT   STRAND      151    153
FT   STRAND      159    161
FT   HELIX       172    176
FT   HELIX       188    191
FT   HELIX       199    214
FT   HELIX       224    235
FT   HELIX       240    242
FT   HELIX       251    253
FT   HELIX       262    264
FT   HELIX       271    280
FT   TURN        285    287
FT   HELIX       291    295
FT   HELIX       298    300
SQ   SEQUENCE   326 AA;  36938 MW;  571733EE6BE7FD4A CRC64;
     MEKDGLCRAD QQYECVAEIG EGAYGKVFKA RDLKNGGRFV ALKRVRVQTG EEGMPLSTIR
     EVAVLRHLET FEHPNVVRLF DVCTVSRTDR ETKLTLVFEH VDQDLTTYLD KVPEPGVPTE
     TIKDMMFQLL RGLDFLHSHR VVHRDLKPQN ILVTSSGQIK LADFGLARIY SFQMALTSVV
     VTLWYRAPEV LLQSSYATPV DLWSVGCIFA EMFRRKPLFR GSSDVDQLGK ILDVIGLPGE
     EDWPRDVALP RQAFHSKSAQ PIEKFVTDID ELGKDLLLKC LTFNPAKRIS AYSALSHPYF
     QDLERCKENL DSHLPPSQNT SELNTA
//
